BioSpace News Archive

Drug Development

Incyte’s Opzelura Clears Phase III Trial in Pediatric Atopic Dermatitis

The company’s ruxolitinib cream Opzelura led to higher rates of treatment success in children with atopic dermatitis than with a control cream.

July 12, 2023
·
2 min read
·
Tristan Manalac
Policy

EU Hits Illumina with Record $476M Fine for Unapproved Grail Deal

For closing its $8 billion acquisition of Grail without regulatory approval, the European Union has slapped Illumina with a record $476 million fine—the maximum sanction allowed under the EU’s rules.

July 12, 2023
·
2 min read
·
Tristan Manalac
Business

NVIDIA Doubles Down on AI Drug Discovery with $50M Recursion Investment

The tech giant is investing $50 million in the Utah-based biotech to accelerate development of its AI foundation models for drug discovery.

July 12, 2023
·
2 min read
·
Connor Lynch
Policy

Takeda Withdraws Dengue Vaccine Application After FDA Request for More Data

Following the regulator’s request for more data beyond the scope of its Phase III TIDES trial, Takeda decided to voluntarily withdraw the Biologics License Application for its TAK-003 dengue vaccine.

July 12, 2023
·
2 min read
·
Tristan Manalac
Employer Resources

Candidates Adjust Expectations as Employers Regain Upper Hand

As the market recovers from the effects of the COVID-19 pandemic, employers are beginning to regain some of the power they lost in recruiting, forcing candidates to adjust their asks.

July 12, 2023
·
2 min read
·
Rosemary Scott
Drug Development

After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes

The FDA recently approved the first cellular therapy for Type 1 diabetes and others may not be far behind. But experts say challenges still exist to the widespread application of these treatments.

July 12, 2023
·
5 min read
·
Heather McKenzie
Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

Immunovia, the diagnostics company focused on early detection of pancreatic cancer, announced plans to restructure its operations.

July 12, 2023
·
3 min read
Southwest Florida Proton selects RayStation

RaySearch Laboratories AB announces that Southwest Florida Proton, USA, has placed an order for the treatment planning system RayStation®* to be installed at its new proton center in Estero, Florida.

July 12, 2023
·
2 min read
Business

Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division

Medicilon, a leading one-stop pharmaceutical preclinical R&D service platform CRO, recently appointed Dr. Liu Jian as the President of Drug Discovery Division.

July 12, 2023
·
4 min read
Deals

ExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic Brand

ExoCoBio is pleased to announce that they have completed the acquisition of a majority ownership in BENEV, a global medical aesthetic company based in the U.S.

July 12, 2023
·
3 min read